IRulya Therapeutics Inc. (IRLA)
NASDAQ: IRLA · Real-Time Price · USD
38.33
-0.29 (-0.75%)
Nov 11, 2026, 4:00 PM EST - Market closed
IRulya Therapeutics Market Cap
IRulya Therapeutics has a market cap or net worth of $38.98 million as of November 11, 2026. It is the 31,801st most valuable company in the world and the 4,735th biggest in the United States. Its market cap has decreased by 54.64% in one year.
Market Cap
38.98M
Enterprise Value
-77.00M
1-Year Change
-54.64%
Global Rank
Country Rank
#4,735 United States
Category
ChartMarket Cap Chart
Since May 9, 2019, IRulya Therapeutics's market cap has decreased from $855.57M to $38.98M, a decrease of -95.44%. That is a compound annual growth rate of -33.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 38.98M | -79.10% |
| Dec 31, 2025 | 186.53M | 126.70% |
| Dec 31, 2024 | 82.28M | 82.80% |
| Dec 29, 2023 | 45.01M | 95.46% |
| Dec 30, 2022 | 23.03M | -93.89% |
| Dec 31, 2021 | 377.06M | -53.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Werewolf Therapeutics | 47.14M |
| Kalaris Therapeutics | 46.66M |
| Telomir Pharmaceuticals | 45.91M |
| Dogwood Therapeutics | 45.11M |
| Connect Biopharma Holdings | 45.01M |
| Elicio Therapeutics | 44.44M |
| Biomea Fusion | 43.61M |
| Hyperion DeFi | 42.97M |